We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Corium’s Alzheimer’s Drug Patch Wins FDA Approval
Corium has nabbed an FDA approval for Adlarity, a once-a-week transdermal donepezil patch intended for patients with mild, moderate, or severe Alzheimer’s disease.